Skip to main content
Vir Biotechnology, Inc. (VIR)
NASDAQ: VIR · IEX Real-Time Price · USD
10.27
-0.12 (-1.15%)
At close: May 31, 2024, 4:00 PM
10.26
-0.01 (-0.10%)
After-hours: May 31, 2024, 4:29 PM EDT

Vir Biotechnology Revenue

Vir Biotechnology had revenue of $79.60M in the twelve months ending March 31, 2024, down -82.16% year-over-year. Revenue in the quarter ending March 31, 2024 was $56.38M, a -10.45% decrease year-over-year. In the year 2023, Vir Biotechnology had annual revenue of $86.18M, a decrease of -94.67%.

Revenue (ttm)
$79.60M
Revenue Growth
-82.16%
P/S Ratio
17.55
Revenue / Employee
$135,603
Employees
587
Market Cap
1.40B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202386.18M-1.53B-94.67%
Dec 31, 20221.62B520.38M47.51%
Dec 31, 20211.10B1.02B1,334.39%
Dec 31, 202076.37M68.28M843.86%
Dec 31, 20198.09M-2.58M-24.16%
Dec 31, 201810.67M7.96M293.94%
Dec 31, 20172.71M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Pacira BioSciences 681.75M
ANI Pharmaceuticals 517.46M
Alphatec Holdings 511.63M
Kiniksa Pharmaceuticals 301.77M
Arcus Biosciences 237.00M
Xencor 162.18M
Establishment Labs Holdings 155.79M
Spyre Therapeutics 688.00K
Revenue Rankings

VIR News

More News